Journal of Applied Physiology, Vol 79, Issue 4 1106-1111, Copyright © 1995 by American Physiological Society

ARTICLES

Endothelin-1 potentiates leukotoxin-induced edematous lung injury

T. Ishizaki, K. Shigemori, T. Nakai, S. Miyabo, M. Hayakawa, T. Ozawa, N. F. Voelkel and S. W. Chang
Department of Internal Medicine, Fukui Medical School, Japan.

We tested the hypothesis that leukotoxin (Lx), a cytochrome P-450-dependent linoleate product of leukocytes, can stimulate the release of endothelin-1 (ET-1) from the lung and further that exogenous ET-1 synergizes with Lx to produce edematous lung injury. In isolated rat lungs perfused with Earle's balanced salt solution, Lx (10 mumol) alone caused lung edema and increased the perfusate and lung tissue ET-1 levels. The combination of ET-1 (5 nM) and Lx (5 mumol), at concentrations that by themselves did not increase wet lung weight, significantly increased wet lung weight, wet-to-dry lung weight ratio, as well as the lung effluent lactate dehydrogenase activity. Pretreatment with BQ-123 (5 x 10(-6) M), an endothelin A receptor antagonist that significantly attenuated the ET-1 (5 nM)-induced increase in pulmonary arterial pressure (Ppa) and pulmonary capillary pressure (Ppc), suppressed the edematous lung injury generated by the combination of ET-1 and Lx, suggesting that the edema-enhancing effect of ET-1 in Lx-treated lungs occurred through endothelin A receptor-dependent elevation of Ppa and Ppc. Elevation of the pulmonary venous pressure in Lx-treated lungs (13.5 cmH2O) mimicked the effect of ET-1 on Ppa and Ppc and produced a degree of lung edema that was comparable to that after combined ET-1 + Lx treatment but without increase in the perfusate lactate dehydrogenase. These data support the idea that ET-1 and Lx promote lung edema in a synergistic fashion.

This article has been cited by other articles:

				S. Zaedi, S. Jesmin, S. Maeda, N. Shimojo, I. Yamaguchi, K. Goto, and T. Miyauchi Alterations in Gene Expressions Encoding PreproET-1 and NOS in Pulmonary Tissue in Endotoxemic Rats. Experimental Biology and Medicine, June 1, 2006; 231(6): 992 - 996. [Abstract] [Full Text] [PDF]

				T. Carpenter, S. Schomberg, W. Steudel, J. Ozimek, K. Colvin, K. Stenmark, and D. D. Ivy Endothelin B Receptor Deficiency Predisposes to Pulmonary Edema Formation via Increased Lung Vascular Endothelial Cell Growth Factor Expression Circ. Res., September 5, 2003; 93(5): 456 - 463. [Abstract] [Full Text] [PDF]

				M. Clozel, C. Qiu, C.-S. Qiu, P. Hess, and J.-P. Clozel Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction J. Am. Coll. Cardiol., January 2, 2002; 39(1): 142 - 147. [Abstract] [Full Text] [PDF]

				T. C. Carpenter and K. R. Stenmark Endothelin receptor blockade decreases lung water in young rats exposed to viral infection and hypoxia Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L547 - L554. [Abstract] [Full Text] [PDF]

				Y. FUJII, S. MAGDER, P. CERNACEK, P. GOLDBERG, Y. GUO, and S. N. A. HUSSAIN Endothelin Receptor Blockade Attenuates Lipopolysaccharide-induced Pulmonary Nitric Oxide Production Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 982 - 989. [Abstract] [Full Text] [PDF]

				C. Morisseau, M. H. Goodrow, D. Dowdy, J. Zheng, J. F. Greene, J. R. Sanborn, and B. D. Hammock Potent urea and carbamate inhibitors of soluble epoxide hydrolases PNAS, August 3, 1999; 96(16): 8849 - 8854. [Abstract] [Full Text] [PDF]